Sadu Capital

Sadu Capital is a Riyadh-based early-stage venture firm investing in software infrastructure and applied AI workflows across Saudi Arabia, with Pre-Seed, Seed, and Series A checks in the $1M to $5M range. The fund’s positioning is technical and infrastructure-oriented, with relevant healthcare surfaces including health IT software, applied AI in clinical and operational workflows, B2B platforms targeting Saudi providers and payers, and infrastructure software that healthcare companies depend on. Founders pursuing biotech, MedTech with multi-year clearance pathways, or pure consumer wellness should look elsewhere. The right founder is a Saudi or MENA technical operator with deep ML or infrastructure depth, building an applied AI or software product with a clear Saudi and broader Gulf wedge. Sadu is most useful when the founder values a fund with technical sophistication and Saudi market depth, particularly aligned with Vision 2030 priorities including healthcare modernization, AI adoption, and digital infrastructure. Geographic and strategic advantage is real Saudi network depth, connectivity into PIF-aligned capital and government programs through SDAIA, NEOM, and broader Vision 2030 initiatives, and emerging cross-border syndication with Tier-1 global investors interested in MENA. Best entry is a warm intro from a portfolio founder, a regional co-investor such as Raed, MEVP, or +VC, or a Saudi corporate or government program operator. Cold inbound is read but conversion is lower. Lead the pitch with technical depth, the data asset, model evaluation rigor, real or proposed Saudi customer relationships, and a credible regional expansion plan. AI healthcare founders should describe Arabic-language model performance, data residency under Saudi PDPL, regulatory posture under SFDA where relevant, and clinical or operational integration with Saudi hospitals. Caveats: Saudi Vision 2030 priorities shape the strategic landscape, and savvy founders align thoughtfully without overcommitting to government-program dependencies. Ask Sadu about reserves, prorata behavior, and which Series B leads have followed it into healthcare portfolio companies. Confirm fund vintage and remaining deployment, since the fund is relatively young in the Saudi VC ecosystem. Reference checks with current portfolio CEOs on operating support, regulator navigation, and Saudi corporate introductions are particularly worth the time. Used appropriately, Sadu is a credible Saudi technical-and-infrastructure partner for healthcare AI founders building toward Saudi and Gulf scale; for founders without a Saudi market angle, the fit is narrower.